Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Vitrafy Life Sciences Ltd. ( (AU:VFY) ) has shared an update.
Vitrafy Life Sciences Limited announced it will release its Quarterly Activities Report and Appendix 4C for the quarter ended 31 March 2025, with an investor briefing scheduled for 2 May 2025. This announcement highlights Vitrafy’s commitment to transparency and engagement with its investors, potentially impacting its market position by reinforcing stakeholder confidence in its innovative cryopreservation solutions.
More about Vitrafy Life Sciences Ltd.
Vitrafy Life Sciences Limited is a company specializing in smart cryopreservation solutions, offering a proprietary range of hardware and Lifechain™, a cloud-based software platform. Their integrated system is designed to maintain the quality of biomaterials, ensuring the integrity of sensitive biological samples during storage. Headquartered in Melbourne, Australia, Vitrafy operates an ISO13485 accredited manufacturing facility and laboratory in Ballarat, Victoria, and is listed on the Australian Securities Exchange (ASX: VFY).
YTD Price Performance: -14.12%
Average Trading Volume: 27,565
Learn more about VFY stock on TipRanks’ Stock Analysis page.